Unlock stock picks and a broker-level newsfeed that powers Wall Street.
MCE - Delayed Quote EUR

Ercros, S.A. (ECR.MC)

Compare
2.8650
+0.0300
+(1.06%)
At close: March 14 at 5:35:10 PM GMT+1

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Antonio Zabalza Marti Executive Chairman of the Board & CEO 610.89k -- 1946
Mr. Pedro Rodríguez Sánchez Chief Financial Officer -- -- --
Mr. Agustín Blasco Franco Chief Operating Officer -- -- --
Mr. Josep Rovira Pujals Director of Administration -- -- --
Ms. Asunción Loste Madoz Director of Legal Department -- -- 1963
Ms. Teresa Conesa Fábregues Director of Institutional Relations & Communications -- -- 1958
Mr. Joaquin Sanmartín Muñiz Director of Human Resources -- -- --
Ms. Maria Chantal Coll d'arnaude Director of Sustainable Development -- -- 1959
Mr. Daniel Ripley Soria Non-Director Secretary -- -- 1970
Mr. Xavier Alvarez Garcia Director of the Internal Audit Service -- -- 1973

Ercros, S.A.

Avinguda Diagonal, 593-595
Barcelona, 08014
Spain
34 609 88 06 30 https://www.ercros.es
Industry: 
Chemicals
Full Time Employees: 
1,318

Description

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers and polychloride. This segment's products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding compunds, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing of particle, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; sockets and switches in the electrical components sector; and tableware, and health and packaging items in the textile tanning industry. The Pharmacy division engages in the production of raw materials and pharmaceutical intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents. This segment's products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, fosfomycin calcium and sodium, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

Corporate Governance

Ercros, S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 28, 2025 at 10:59 AM UTC - May 2, 2025 at 12:00 PM UTC

Ercros, S.A. Earnings Date

Recent Events

July 8, 2024 at 12:00 AM UTC

Ex-Dividend Date